• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自有和没有冠状动脉疾病受试者的富含和缺乏唾液酸的低密度脂蛋白中蛋白质和脂质成分的碳水化合物组成。

Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.

作者信息

Tertov V V, Orekhov A N, Sobenin I A, Morrisett J D, Gotto A M, Guevara J G

机构信息

Institute of Experimental Cardiology, Russian Cardiology Research Center, Moscow.

出版信息

J Lipid Res. 1993 Mar;34(3):365-75.

PMID:8468522
Abstract

Low density lipoprotein (LDL) from patients with coronary heart disease (CHD) caused 78-286% increase in accumulation of cholesterol in human aortic subendothelial cells compared to 2-17% caused by LDL from normal subjects. Ricin-Sepharose affinity chromatography was used to separate LDL into two subfractions, one sialic acid-rich (SAR) and the other sialic acid-poor (SAP). SAP-LDL from CHD patients caused 156-307% increase in accumulation of cellular cholesterol, whereas SAR-LDL from these patients caused only 14-21% increase. SAP-LDL from normal healthy subjects caused 50-86% increased accumulation, whereas their SAR-LDL induced only 2-12% increase. Carbohydrate analysis of SAP-LDL protein isolated from four CHD patients revealed mean values of 59, 25, 61, and 11 nmoles of N-acetyl glucosamine, galactose, mannose, and sialic acid per mg protein, respectively. Mean values for SAR-LDL protein from these patients were 59, 31, 77, and 24 nmol/mg protein, respectively. Analysis of SAP-LDL protein from four normal healthy subjects indicated respective mean values of 58, 29, 72, and 22 nmol/mg, whereas SAR-LDL protein from normals contained 59, 29, 72, and 29 nmol/mg. The carbohydrate content of LDL lipids represents about 25% of the total carbohydrate present in the lipoprotein. The mean values for SAP-LDL lipids from four CHD patients were about 2, 2, 18, 18, and 2 nmol/mg protein for N-acetyl galactosamine, N-acetyl glucosamine, galactose, glucose, and sialic acid, respectively. The mean values for SAR-LDL lipids from these patients were 3, 4, 34, 41, and 5 nmol/mg, respectively. Analysis of SAP-LDL lipids from four normal healthy subjects indicated respective mean values of 4, 6, 30, 31, and 3 nmol/mg, whereas SAR-LDL lipids from these subjects contained 6, 9, 41, 46, and 7 nmol/mg. These results suggest that the different biological properties of SAR-LDL and SAP-LDL are related to their different carbohydrate compositions.

摘要

与正常受试者的低密度脂蛋白(LDL)导致人主动脉内皮下细胞胆固醇蓄积增加2%-17%相比,冠心病(CHD)患者的LDL可使胆固醇蓄积增加78%-286%。采用蓖麻毒蛋白-琼脂糖亲和色谱法将LDL分离为两个亚组分,一个富含唾液酸(SAR),另一个唾液酸含量低(SAP)。冠心病患者的SAP-LDL可使细胞胆固醇蓄积增加156%-307%,而这些患者的SAR-LDL仅使胆固醇蓄积增加14%-21%。正常健康受试者的SAP-LDL可使胆固醇蓄积增加50%-86%,而其SAR-LDL仅诱导增加2%-12%。对从4例冠心病患者分离的SAP-LDL蛋白进行碳水化合物分析,结果显示每毫克蛋白中N-乙酰葡糖胺、半乳糖、甘露糖和唾液酸的平均值分别为59、25、61和11纳摩尔。这些患者的SAR-LDL蛋白的平均值分别为59、31、77和24纳摩尔/毫克蛋白。对4例正常健康受试者的SAP-LDL蛋白分析表明,其平均值分别为58、29、72和22纳摩尔/毫克,而正常受试者的SAR-LDL蛋白含有59、29、72和29纳摩尔/毫克。LDL脂质中的碳水化合物含量约占脂蛋白中总碳水化合物的25%。4例冠心病患者的SAP-LDL脂质中,N-乙酰半乳糖胺、N-乙酰葡糖胺、半乳糖、葡萄糖和唾液酸的平均值分别约为2、2、18、18和2纳摩尔/毫克蛋白。这些患者的SAR-LDL脂质的平均值分别为3、4、34、41和5纳摩尔/毫克。对4例正常健康受试者的SAP-LDL脂质分析表明,其平均值分别为4、6、30、31和3纳摩尔/毫克,而这些受试者的SAR-LDL脂质含有6、9、41、46和7纳摩尔/毫克。这些结果表明,SAR-LDL和SAP-LDL不同的生物学特性与其不同的碳水化合物组成有关。

相似文献

1
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.来自有和没有冠状动脉疾病受试者的富含和缺乏唾液酸的低密度脂蛋白中蛋白质和脂质成分的碳水化合物组成。
J Lipid Res. 1993 Mar;34(3):365-75.
2
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.导致细胞内脂质蓄积的多种修饰去唾液酸低密度脂蛋白。分离、分级分离及特性鉴定。
Lab Invest. 1992 Nov;67(5):665-75.
3
Carbohydrate composition of circulating multiple-modified low-density lipoprotein.循环中多重修饰低密度脂蛋白的碳水化合物组成
Vasc Health Risk Manag. 2016 Oct 14;12:379-385. doi: 10.2147/VHRM.S112948. eCollection 2016.
4
[Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].[冠状动脉粥样硬化患者血浆中天然及去唾液酸低密度脂蛋白的碳水化合物组成]
Kardiologiia. 1992 Sep;32(9-10):57-61.
5
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
Coron Artery Dis. 1993 Apr;4(4):379-85. doi: 10.1097/00019501-199304000-00010.
6
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation.人低密度脂蛋白的唾液酸含量会影响其与细胞受体的相互作用以及细胞内脂质积累。
J Lipid Res. 1992 Jun;33(6):805-17.
7
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.导致细胞内脂质蓄积的去唾液酸低密度脂蛋白的特性分析
Int J Tissue React. 1992;14(4):155-62.
8
Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.去唾液酸低密度脂蛋白——具有致动脉粥样硬化潜能的天然存在的修饰脂蛋白。
Atherosclerosis. 1991 Feb;86(2-3):153-61. doi: 10.1016/0021-9150(91)90211-k.
9
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.人血浆转唾液酸酶会导致低密度脂蛋白发生致动脉粥样硬化的修饰。
Atherosclerosis. 2001 Nov;159(1):103-15. doi: 10.1016/s0021-9150(01)00498-1.
10
Sialic acid content of low-density lipoprotein in women with coronary artery disease.
J Lab Clin Med. 2000 Aug;136(2):110-5. doi: 10.1067/mlc.2000.108148.

引用本文的文献

1
The Link between Lipids and Inflammation: Focus on Targeting Sialidase Activity as a Novel Strategy for Anti-Atherosclerotic Therapy.脂质与炎症之间的联系:聚焦于靶向唾液酸酶活性作为抗动脉粥样硬化治疗的新策略。
Curr Med Chem. 2025;32(15):2887-2898. doi: 10.2174/092986733215250325111534.
2
Biological function of sialic acid and sialylation in human health and disease.唾液酸及唾液酸化在人类健康与疾病中的生物学功能
Cell Death Discov. 2024 Sep 30;10(1):415. doi: 10.1038/s41420-024-02180-3.
3
VLDL Biogenesis and Secretion: It Takes a Village.
极低密度脂蛋白的生物合成与分泌:众人拾柴火焰高。
Circ Res. 2024 Jan 19;134(2):226-244. doi: 10.1161/CIRCRESAHA.123.323284. Epub 2024 Jan 18.
4
Systematic Assessment of Protein C-Termini Mutated in Human Disorders.系统性评估人类疾病中突变的蛋白质 C 末端。
Biomolecules. 2023 Feb 12;13(2):355. doi: 10.3390/biom13020355.
5
Lipoprotein sialylation in atherosclerosis: Lessons from mice.载脂蛋白唾液酸化在动脉粥样硬化中的作用:来自小鼠的启示。
Front Endocrinol (Lausanne). 2022 Sep 6;13:953165. doi: 10.3389/fendo.2022.953165. eCollection 2022.
6
Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov.弗拉基米尔·特尔托夫发现去唾液酸脂蛋白的35年历史。
Biomedicines. 2022 May 19;10(5):1174. doi: 10.3390/biomedicines10051174.
7
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages.神经氨酸酶 1 和 3 通过脱唾液酸化低密度脂蛋白并增加其被巨噬细胞摄取来引发动脉粥样硬化。
J Am Heart Assoc. 2021 Feb 16;10(4):e018756. doi: 10.1161/JAHA.120.018756. Epub 2021 Feb 6.
8
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis.电负性低密度脂蛋白胆固醇在动脉粥样硬化血栓形成中的临床意义
Biomedicines. 2020 Jul 30;8(8):254. doi: 10.3390/biomedicines8080254.
9
Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?可能导致泡沫细胞形成的信号通路:胆固醇蓄积还是炎症反应——哪个是首要的?
Int J Mol Sci. 2020 Apr 14;21(8):2716. doi: 10.3390/ijms21082716.
10
Carbohydrate composition of circulating multiple-modified low-density lipoprotein.循环中多重修饰低密度脂蛋白的碳水化合物组成
Vasc Health Risk Manag. 2016 Oct 14;12:379-385. doi: 10.2147/VHRM.S112948. eCollection 2016.